Compass Pathways PLC CMPS said a White House executive order aimed at accelerating mental health treatment research could ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical ...
Investor's Business Daily on MSN
How Trump sent psychedelics-tied Compass Pathways and others flying
Compass Pathways stock surged Monday after President Donald Trump signed an executive order tied to psychedelic drugs.
The FDA is awarding national priority vouchers to Compass Pathways and the Usona Institute as the Trump administration looks ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that CEO Kabir Nath will ...
Shares of the biotechnology company rocketed more than 50% this morning and were still higher by 41.2% at noon ET. Compass is ...
In addition to the three NPVs, the FDA also announced the approval of an IND submission for DemeRx, which is investigating ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical tre ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results